The average one-year price target for Core Laboratories (NYSE:CLB) has been revised to $15.64 / share. This is an increase of 11.51% from the prior estimate of $14.02 dated September 27, 2025. The ...

(1) Three months ended September 30, 2024 includes reversals of stock compensation expense previously recognized due to a change in probability of performance condition for certain executive's share ...

Gwendolyn Schreffler, Senior Vice President, projected Core's fourth quarter 2025 revenue to range from $132 million to $136 million with operating income of $14 million to $16.1 million and operating ...

Ariel Investments, an investment management company, released its “Ariel Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The second quarter was a volatile ...

HOUSTON, July 23, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported second quarter 2025 revenue of ...

Wide-moat Core Laboratories posted third-quarter results mostly in line with our estimates. Revenue of $134 million was up 3% sequentially and 7% year over year, while operating income of $20 million ...

probability of performance condition for certain executive's share awards. (2) Three months ended June 30, 2025 and September 30, 2025 includes the write-down of inventory. (3) Three months ended June ...